Chiesi Farmaceutici S.p.a.

This study tests a once-daily tablet called CHF10196 (Florensocatib) to see if it can reduce the number of lung flare-ups (exacerbations) in people with bronchiectasis, a chronic lung disease. About 1808 participants aged 12 to 85 will be randomly assigned to receive either the d…

This study tests whether a new inhaler with three medicines (CHF 5993) works better than a standard two-medicine inhaler for people whose asthma is not well controlled. About 554 Chinese adults with asthma will use either the triple or dual inhaler for 24 weeks. The main goal is …

This study tests an experimental drug called zampilimab in 240 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. Participants will receive one of two doses of the drug or a placebo for 24 weeks, with an optional 24-week…